Studio di oncologia personalizzata per la valutazione di terapie bersaglio nel trattamento di sarcomi muscolo scheletrici

Title

Code

PENELOPE

Type

Sperimentale

Start Year

2023

Status

Terminato

Principal Investigator

051-6366760

katia.scotlandi@ior.it

Scotlandi Katia, MSc

Head

Laboratory of Experimental Oncology

Operational unit that carry out the study

departmental simple unit

Laboratorio di Oncologia sperimentale

Head

Scotlandi Katia, MSc

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PENELOPE

Tuesday 10 January 2023, 13:50

PG0000168_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Studio di oncologia personalizzata per la valutazione di terapie bersaglio nel trattamento di sarcomi muscolo scheletrici

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in